Scintiangiography of hepatic masses in childhood

JAMA
|June 23, 1978
PubMed

Insights

Technetium Tc 99m sulfur colloid hepatic scintigraphy with scintiangiography helps differentiate pediatric liver tumors. Hypervascularity on scans indicates primary tumors, while hypovascularity suggests metastases or other non-tumor masses.

Area of Science:

  • Pediatric Radiology
  • Nuclear Medicine
  • Hepatobiliary Imaging

Background:

  • Distinguishing intrahepatic masses in children is crucial for appropriate management.
  • Technetium Tc 99m sulfur colloid hepatic scintigraphy is a common diagnostic tool.

Observation:

  • Forty-three pediatric patients with intrahepatic masses underwent hepatic scintigraphy and scintiangiography.
  • Scintiangiography assessed the vascularity of these liver masses.

Findings:

  • Hypervascularity was observed in approximately one-third of the intrahepatic masses.
  • Hypervascularity was exclusively associated with primary liver tumors: hepatomas, hepatoblastomas, hepatic adenomas, and cavernous hemangiomas.
  • Metastases, abscesses, and hematomas presented as hypovascular lesions.

Implications:

  • Routine inclusion of scintiangiography can aid in differentiating primary hypervascular liver tumors from hypovascular masses.
  • This technique may improve diagnostic accuracy and guide treatment decisions in pediatric liver lesions.
  • Static scintigrams alone can be indistinguishable between various hypovascular intrahepatic masses.